Načítá se...
P14.99 Clinical and biologic features predictive of survival after relapse of childhood medulloblastoma
BACKGROUND: Salvage therapy for recurrent medulloblastoma (MB) is not standardized. Factors associated with survival after recurrence have not been reported. MATERIAL AND METHODS: Medical records were reviewed for 155 consecutive patients with newly diagnosed MB between 2007 and 2017, treated at Gus...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6795869/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.334 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|